Abstract
A 25-year-old otherwise healthy female with history of chronic constipation is found to have chronic hypokalemia. She denies any other gastrointestinal symptoms including nausea, vomiting, or diarrhea. She denies taking any medications. Family history is unremarkable as is her physical examination. Her BMI is 29. Lab results show:
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gennari FJ. Hypokalemia. N Engl J Med. 1998;339(7):451–8.
Paltiel O, et al. Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases. Arch Intern Med. 2001;161(8):1089–95.
Mount DB, Zandi-Nejad K. Disorders of potassium balance. In: Brenner BM, editor. Brenner & Rector’s the kidney. Philadelphia: W.B. Saunders; 2008. p. 547–669.
Mount D, Zandi-Nejad K. Disorders of potassium balance. In: Taal MW et al., editors. Brenner & Rector’s the kidney. Philadelphia: Elsevier Saunders; 2012. p. 640–688.
Stevens MS, Dunlay RW. Hyperkalemia in hospitalized patients. Int Urol Nephrol. 2000;32(2):177–80.
Zandi-Nejad K, Tang C. Disorders of potassium. In: McKean S, Bennett A, Halasyamani L, editors. Hospital medicine: Just the facts. New York: The McGraw-Hill; 2008. p. 484–94.
DeFronzo RA, et al. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. J Clin Invest. 1978;61(2):472–9.
Costanzo LS. Physiology. 4th ed. Philadelphia: Saunders Elsevier; 2010.
Rose B, Post T. Clinical physiology of acid–base and electrolyte disorders. 5th ed. New York: McGrraw-Hill; 2001. p. 794–930.
Shafi T, et al. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008;52(6):1022–9.
Freeman SJ, Fale AD. Muscular paralysis and ventilatory failure caused by hyperkalaemia. Br J Anaesth. 1993;70(2):226–7.
Matsuda O, et al. Primary role of hyperkalemia in the acidosis of hyporeninemic hypoaldosteronism. Nephron. 1988;49(3):203–9.
Szylman P, et al. Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med. 1976;294(7):361–5.
Sterns RH, et al. Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore). 1981;60(5):339–54.
Cohn JN, et al. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429–36.
Gabduzda GJ, Hall 3rd PW. Relation of potassium depletion to renal ammonium metabolism and hepatic coma. Medicine (Baltimore). 1966;45(6):481–90.
Jaeger P, Karlmark B, Giebisch G. Ammonium transport in rat cortical tubule: relationship to potassium metabolism. Am J Physiol. 1983;245(5 Pt 1):F593–600.
Nicolis GL, et al. Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med. 1981;141(1):49–53.
Villamil MF, et al. Anion effects on cation movements during correction of potassium depletion. Am J Physiol. 1975;229(1):161–6.
Su M, et al. Sustained-release potassium chloride overdose. J Toxicol Clin Toxicol. 2001;39(6):641–8.
Kruse JA, Carlson RW. Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med. 1990;150(3):613–7.
Kunin AS, Surawicz B, Sims EA. Decrease in serum potassium concentrations and appearance of cardiac arrhythmias during infusion of potassium with glucose in potassium-depleted patients. N Engl J Med. 1962;266:228–33.
Seftel HC, Kew MC. Early and intensive potassium replacement in diabetic acidosis. Diabetes. 1966;15(9):694–6.
Kim GH, Han JS. Therapeutic approach to hypokalemia. Nephron. 2002;92 Suppl 1:28–32.
Eiro M, Katoh T, Watanabe T. Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. N Engl J Med. 2002;346(2):140.
Davey M, Caldicott D. Calcium salts in management of hyperkalaemia. Emerg Med J. 2002;19(1):92–3.
Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin Dial. 2001;14(5):348–56.
Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med. 2005;20(5):272–90.
Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int. 1990;38(5):869–72.
Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int. 1993;43(6):1197–209.
Perazella MA. Approach to hyperkalemic end-stage renal disease patients in the emergency department. Conn Med. 1999;63(3):131–6.
Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol. 1995;6(4):1134–42.
Liou HH, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis. 1994;23(2):266–71.
Blumberg A, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med. 1988;85(4):507–12.
Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int. 1992;41(2):369–74.
Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis. 1996;28(4):508–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zandi-Nejad, K. (2013). Potassium Disorders. In: Lerma, E., Rosner, M. (eds) Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4454-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4454-1_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4453-4
Online ISBN: 978-1-4614-4454-1
eBook Packages: MedicineMedicine (R0)